Unlocking
the future
of medicine

About us

Offering an unrivalled modular platform and tailored hyper-targeting is how we stand apart

Pipeline

Reducing the impact of cancer and infectious diseases on people’s lives is why we’re here

Innovation and research

Pushing the boundaries of human advancement in medicine is what drives us every day

Investors
 
 
 

A vaccine platform that unlocks unlimited possibilities for the future of medicine

The Nykode Therapeutics platform is built around the Vaccibody molecule. Inducing fast, strong and long-lasting immune responses, and demonstrating a positive safety profile, our pioneering Vaccibody™ vaccine has the potential to treat many disease areas, including cancer.

Highlights

Nykode Therapeutics Initiates Phase 1/2a Trial of VB10.16 in ...

Read More
29 September 2023

Nykode Therapeutics – presentation from Capital Markets Day in ...

Read More
27 September 2023

Nykode Therapeutics – Capital Markets Day in Oslo on ...

Read More
27 September 2023

Nykode Therapeutics – Capital Markets Day in Oslo on ...

Read More
25 September 2023

Nykode Therapeutics – Capital Markets Day in New York ...

Read More
20 September 2023

Nykode Therapeutics – Capital Markets Day in New York ...

Read More
20 September 2023

Nykode Therapeutics to Present at H.C. Wainwright 25th Annual ...

Read More
14 September 2023

Nykode Therapeutics – Invitation to Capital Markets Day in ...

Read More
14 September 2023

H.C. Wainwright 25th Annual Global Investment Conference, September 11, ...

Read More
11 September 2023